Perhaps also consider the patients who continue to receive clopidogrel without PGx testing despite an FDA black box, first added in 2010, warning that patients with certain PGx variants are more likely to have another heart attack or stroke. The promise of PGx testing Biomarker testing, including...
Platelet count, size and turnover were not affected by SSRI treatment. In conclusion, SSRI therapy did not lead to statistically significant inhibition of platelet aggregation in ischaemic stroke patients treated with clopidogrel.doi:10.1038/s41598-019-56487-8Kristian Lundsgaard Kraglund...
The use of a combined therapy with low doses of estrogens plus antidepressants to treat depression associated to perimenopause could be advantageous. However the use of these combinations is controversial due to several factors, including the time of int
Personalized medicine based on CYP2C19 genotyping could evolve as a promising new avenue towards mitigating Escitalopram and Citalopram therapy and the associated side effects and enhancing treatment success. Keywords: SSRI; pharmacogenetic; adverse effects; phenotype; efficacy ...
However, Henderson and Popat [16] in a systematic review, reported that the literature is not enough to support or decline this hypothesis. Estrogen replacement therapy (ERT) is an effective treatment for depression associated to perimenopause, along with its beneficial effects on other climacteric ...